Previous reports indicated that non-steroidal anti-inflammatory drugs (NSAIDs) suppress bone repair. Our previous study further found that ketorolac delayed the endochondral bone formation, and the critical effective timing was at the early stage of repair. Furthermore, we found that NSAIDs suppressed proliferation and induced cell death of cultured osteoblasts. In this study, we hypothesized that chondrocytic proliferation and death, which plays an important role at the early stage of endochondral bone formation, might be affected by NSAIDs. Non-selective NSAIDs, indomethacin, ketorolac, diclofenac and piroxicam; cyclooxygenase-2 (COX-2) selective NSAIDs, celecoxib and DFU (an analog of rofecoxib); prostaglandins (PGs), PGE1, PGE2 and PGF2alpha; and each NSAID plus each PG were tested. The effects of NSAIDs on proliferation, cell cycle kinetics, cytotoxicity and cell death of epiphyseal-articular chondrocytes of fetal rats were examined. The results showed that all the tested NSAIDs, except DFU, inhibited thymidine incorporation of chondrocytes at a concentration range (10(-8) to 10(-4)M) covering the theoretic therapeutic concentrations. Cell cycle was arrested by NSAIDs at the G(0)/G(1) phase. Upon a 24h treatment, LDH leakage and cell death (both apoptosis and necrosis) were significantly induced by the four non-selective NSAIDs in chondrocyte cultures. However, COX-2 inhibitors revealed non-significant effects on cytotoxicity of chondrocytes except higher concentration of celecoxib (10(-4)M). Replenishments of PGE1, PGE2 or PGF2alpha could not reverse the effects of NSAIDs on chondrocytic proliferation and cytotoxicity. In this study, we found that therapeutic concentrations of non-selective NSAIDs caused proliferation suppression and cell death of chondrocytes, suggesting these adverse effects may be one of the reasons that NSAIDs delay the endochondral ossification during bone repair found in previous studies. Furthermore, these effects of NSAIDs may act via PG-independent mechanisms. COX-2 selective NSAIDs showed less deleterious effects on chondrocytic proliferation and death.

译文

以前的报道表明非甾体抗炎药 (NSAIDs) 抑制骨修复。我们先前的研究进一步发现,酮洛尔可延迟软骨内骨的形成,并且关键的有效时机是在修复的早期。此外,我们发现NSAIDs抑制了培养的成骨细胞的增殖并诱导了细胞死亡。在这项研究中,我们假设NSAIDs可能会影响软骨细胞的增殖和死亡,这在软骨内骨形成的早期阶段起着重要作用。非选择性NSAIDs,吲哚美辛,酮咯酸,双氯芬酸和吡罗昔康; cyclooxygenase-2 (COX-2) 选择性NSAIDs,塞来昔布和DFU (罗非考昔的类似物); 前列腺素 (PGs),PGE1,PGE2和pgf2α; 以及每个NSAID加上每个PG。研究了NSAIDs对胎鼠epi关节软骨细胞增殖,细胞周期动力学,细胞毒性和细胞死亡的影响。结果表明,除DFU外,所有测试的NSAIDs均在覆盖理论治疗浓度的浓度范围 (10(-8) 至10(-4)M) 下抑制胸苷掺入软骨细胞。NSAIDs在G(0)/G(1) 期阻止了细胞周期。处理24小时后,软骨细胞培养物中的四种非选择性NSAIDs显着诱导了LDH泄漏和细胞死亡 (凋亡和坏死)。然而,除了较高浓度的塞来昔布 (10(-4)M) 外,COX-2抑制剂对软骨细胞的细胞毒性无显着影响。补充PGE1,PGE2或PGF2alpha不能逆转NSAIDs对软骨细胞增殖和细胞毒性的影响。在这项研究中,我们发现治疗浓度的非选择性NSAIDs导致软骨细胞增殖抑制和细胞死亡,这可能是先前研究发现的NSAIDs延迟骨修复过程中软骨内骨化的原因之一。此外,NSAIDs的这些作用可能通过PG独立机制起作用。COX-2选择性NSAIDs对软骨细胞增殖和死亡的有害作用较小。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录